Jacobson Catherine 4

What Happened

• Catherine Jacobson, a director of Teladoc Health (TDOC), reported conversion/exercise of restricted stock units (RSUs) and a new RSU award. On 2026-05-20 she converted/realized 28,986 RSUs into shares (reported as an acquired conversion and a simultaneous disposal of 28,986 shares at $0). On 2026-05-21 she was granted 30,441 RSUs (reported as an award at $0).
• Reported prices/values: the conversion shows acquisition at N/A and a disposal at $0 (derivative); the new award is granted at $0. No cash purchase or market sale is reported.

Key Details

• Transaction dates and codes: 2026-05-20 (code M: exercise/conversion of derivative — 28,986 shares acquired and 28,986 shares disposed at $0); 2026-05-21 (code A: grant/award — 30,441 RSUs).
• Vesting/history: Footnote F2: the 28,986 RSUs were originally granted on 2025-05-22 and vested in full on 2026-05-20. Footnote F4: the 30,441 RSU grant vests in full on the earlier of May 21, 2027 or the day before the issuer’s 2027 annual meeting.
• RSU mechanics: Footnotes F1 and F3 state each RSU converts one-for-one into TDOC common stock and represents a contingent right to one share.
• Shares owned after transaction: Not disclosed in this filing.
• Timeliness: Filing covers transactions through 2026-05-20 and was filed 2026-05-21 — not marked late.

Context

• These records reflect RSU vesting/conversion and a new RSU grant rather than an open-market buy or sale. The reported disposal of vested shares at $0 is commonly how filings show shares withheld or transferred to satisfy tax-withholding obligations on vested awards (the form does not spell out withholding mechanics here). The new 30,441 RSUs are subject to future vesting per the footnote schedule.